Counterintuitively, in patients with IIM, ILD may precede muscular symptoms in about 20% of cases and factors such as older age at presentation, lower forced vital capacity (FVC), high serum ferritin levels, and presence of anti-MDA5 autoantibodies, all lead to less favourable outcomes [15]. The gene discussed is IFIH1; the disease is interstitial lung disease.